Liver Diseases in PLWH
NCT04446156 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2020-06-30
Summary
In Highly Active Antiretroviral Therapy era, fatty liver has become an important cause of liver function damage in people living with HIV (PLWH). There are a large number of PLWH in China who are infected with hepatitis B virus and hepatitis C virus. HIV, hepatitis B virus, hepatitis C virus, drugs, alcohol, etc. affect each other, which makes the cause, diagnosis, and treatment of liver function damage in PLWH complicated in China.
The investigators plan to conduct a large-scale questionnaire survey among PLWH in Zhejiang Province to assess liver function, detect liver Injuries early, and analyze HIV, hepatitis B virus, hepatitis C virus, anti-HIV drugs, alcohol and other factors associate with liver injuries in PLWH, to provide basis for the treatment and prevention of liver disease in PLWH in eastern China.
Conditions
Sponsors & Collaborators
-
First Affiliated Hospital of Zhejiang University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-26
- Primary Completion
- 2020-08-31
- Completion
- 2020-12-30
Countries
- China
Study Locations
More Related Trials
-
Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
NCT05330923 ·Status: RECRUITING
-
Prevalence of Advanced Fibrosis in Patients Living With HIV
NCT04066608 ·Status: ENROLLING_BY_INVITATION
-
HIV Accelerated Liver Disease in Uganda
NCT01524562 ·Status: COMPLETED
-
The Role of Ectopic Fat and Heart Attack Risk in HIV
NCT06784154 ·Status: RECRUITING
-
Factors Associated With Advanced HIV and Poor Nutrition Among People Living With HIV
NCT06852430 ·Status: NOT_YET_RECRUITING
-
Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study
NCT01634477 ·Status: COMPLETED
-
The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease
NCT06113003 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy
NCT00326482 ·Status: COMPLETED
-
Liver Steatosis and Stiffness in HIV
NCT03599882 ·Status: UNKNOWN
-
Functional Decline and QoL in People Aging with HIV in Asia
NCT04212884 ·Status: COMPLETED
-
Hepatocellular Carcinoma in HIV-infected Patients
NCT02785835 ·Status: COMPLETED
-
HIV Care Cascade and Linkage to Antiretroviral Therapy Among Hospitalized Adults in Lusaka, Zambia
NCT03158844 ·Status: COMPLETED
-
Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons
NCT00889577 ·Status: COMPLETED
-
Nutritional Status Among naïve HIV Infected Patients and HIV Infected Patients Receiving Highly Active Antiretroviral Therapy
NCT01899157 ·Status: COMPLETED
-
Relationship of Metabolic Abnormalities to Hepatic Steatosis in HIV
NCT00575757 ·Status: COMPLETED
-
Characterization of Visceral Adiposity in HIV Mono-infected Patients With NAFLD
NCT05359471 ·Status: UNKNOWN ·Phase: NA
-
HIV Liver Regeneration Project for HIV Patients With Cirrhosis by Autologous Bone Marrow Transplantation
NCT01309594 ·Status: UNKNOWN ·Phase: NA
-
The Evaluations of Cardiovascular Changes in Long-term Treated HIV-infected Individuals
NCT04463810 ·Status: UNKNOWN
-
Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions
NCT00152815 ·Status: TERMINATED ·Phase: PHASE2
-
HIV Assessment in Fuyang, Anhui Province, China
NCT00094354 ·Status: COMPLETED
-
Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa
NCT02060162 ·Status: COMPLETED
-
DENTAL CARE OF PATIENTS LIVING WITH HIV
NCT05123547 ·Status: COMPLETED
-
Clinical Outcomes of People Who Acquired HIV in Early Life
NCT01656564 ·Status: COMPLETED
-
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
NCT07143968 ·Status: RECRUITING ·Phase: PHASE2
-
Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy
NCT02684591 ·Status: COMPLETED ·Phase: PHASE2